The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Fibrin Tissue Adhesive

Fibrin Tissue Adhesive

Fibrin Tissue Adhesive is a biological adhesive derived from human fibrinogen and thrombin, used to promote hemostasis and tissue sealing in surgical procedures.
It functions by mimicking the final stage of the coagulation cascade, forming a fibrin clot that adheres to tissue surfaces.
Fibrin Tissut Adhesive is widely employed in various medical and surgical applications, including wound closure, hemostasis, and tissue engineering.
Its versatile properties make it a valuable tool for clinicians and researchers working in the field of regenerative medicine and wound management.

Most cited protocols related to «Fibrin Tissue Adhesive»

Commercially available fibrin sealants consist of human thrombin and fibrinogen, which might transmit infectious diseases [16 ]. Researchers at the Center for the Study of Venoms and Venomous Animals at UNESP (Centro de Estudos de Venenos e Animais Peçonhentos da UNESP), São Paulo State University therefore proposed a new sealant produced from the thrombin-like enzyme extracted from snake venom and animal fibrinogen. The sealant was produced in this study according to the proposed standardization [15 -17 ,21 ]. The product was provided in three microtubes that were stored at -20°C. Upon use, the components were mixed in the previously set proportions to generate a stable clot with a dense fibrin network.
Full text: Click here
Publication 2014
Animals Clotrimazole Communicable Diseases Enzymes Fibrin Fibrinogen Fibrin Tissue Adhesive Homo sapiens Snake Venoms Thrombin Venoms
The establishment of BCP was vividly described in our previous papers.40 (link),41 (link) Female SD rats (except the naive group) were anesthetized with pentobarbital sodium (60 mg/kg, i.p.). In order to provide a clear view of the proximal tibia, an aseptic incision was gently made on the left leg. After careful drilling of a tiny hole on the exposed proximal tibia, the size of the needle that best fitted the Feige microsyringe was used. Walker 256 breast cancer cells (10 µl, 1 × 106/ml) or heat-inactivated Walker 256 breast cancer cells (10 µl, 1 × 106/ml) (sham group) were slowly injected into the marrow cavity. After waiting for a moment to balance the pressure, the microsyringe was removed, and then the hole was sealed with bone wax immediately. Finally, an aseptic incision was sutured with fibrin glue.
Publication 2019
Aftercare Asepsis Cells Dental Caries Fibrin Tissue Adhesive Malignant Neoplasm of Breast Marrow Needles Pentobarbital Sodium Pressure Rattus norvegicus Tibia Walkers Woman
Burst pressure testing was performed using a published method35 (link). Briefly, a piece of 4 × 4 cm porcine sausage skin membrane was cut and cleaned to remove any excess fat. The membrane was fixed to the measurement device linked to a syringe pump filled with PBS solution. A 2 mm incision was made on the sausage skin membrane surface and the membrane surface was kept wet. Then, 500 μL precursor solutions were injected onto the incision, after which the hydrogels formed in situ on the puncture site after UV illumination. The thickness of the hydrogels was ~4.4 mm and burst pressure was measured after gel formation. Peak pressure before pressure loss was considered the burst pressure. All measurements were repeated three times. Fibrin Glue (Shanghai RAAS Blood Products, Co., Ltd, Shanghai, China), CA (Beijing Compont Medical Devices, Co., Ltd, Beijing, China), and SurgifloTM (Ethicon, Inc., Somerville, NJ) were tested using the same parameters and conditions.
Full text: Click here
Publication 2019
BLOOD Fibrin Tissue Adhesive Hydrogels Medical Devices Pigs Pressure Punctures Skin Syringes Tissue, Membrane Ultraviolet Rays
Sixteen New Zealand white rabbits, weighing 2.8 to 3.5 kg, underwent survival surgeries as summarized in Table I and as detailed previously.16 (link),17 (link) After laryngofissure, the membranous cover layer was resected from the left true vocal fold (known in rabbits as the inferior division of the thyroarytenoid fold) by sharp dissection. Cordectomy extended from the anterior commissure to the vocal process of the arytenoid cartilage, at the interface between lamina propria and thyroarytenoid muscle, equivalent to European Laryngological Society type 2 cordectomy. All right vocal folds remained as uninjured controls. Immediately following resection, one of three reconstructions was performed. Six rabbits had immediate replacement of the resected cover.16 (link) Four sutures of 6-0 plain gut at the corners of the replanted tissue secured it in position, and fibrin glue prepared from rabbit fibrinogen was applied at the interface to ensure adhesion. Eight rabbits had COVR implants with male ASC, similarly secured. Two rabbits served as injured controls and were treated only with fibrin glue over the defect. Five rabbits (one autologous replant, two COVRs, and two controls) underwent endoscopy at 2 weeks postoperative. All were euthanized after 4 weeks and larynges harvested.
Publication 2017
Arytenoid Cartilage Dissection Endoscopy Europeans Fibrinogen Fibrin Tissue Adhesive Lamina Propria Larynx Males New Zealand Rabbits Operative Surgical Procedures Oryctolagus cuniculus Rabbits Reconstructive Surgical Procedures Sutures Thyroarytenoid Muscles Tissue, Membrane Tissues Vocal Cords
Liver samples were prepared using a 20 mm diameter punch (or an 8 mm punch for poroelasticy experiments) (CL Presser, Philadelphia, PA), with all punches taken in the same orientation. The height of the slices ranged from 3.05 to 5.6 mm in the uncompressed state. Samples were kept hydrated during all experiments with HBSS or (for decellularized livers) PBS. Parallel plate shear rheometry was carried out on an RFS3 rheometer (TA instruments, New Castle, DE) at room temperature using TA Orchestrator software (TA instruments) (Fig 1). Normal forces were simultaneously measured from the analog signal of the RFS3 and collected using Logger Pro software (Vernier Software and Technology, Beaverton, OR).
For all measurements unless otherwise indicated, the upper platen (25 mm diameter) was initially lowered to touch the sample and 10 g of nominal initial force (~300 Pa) was applied to ensure adhesive contact of the sample with the plates. Unless noted, measurements were taken in the following order: dynamic time sweep test (2% constant strain, oscillation frequency 1 radian/s, measurements taken for 120 s, every 20 s); dynamic strain sweep test (increasing strain amplitude from 1 to 50%, measurements taken at 5% increments, oscillation frequency 10 radians/s). Tests were carried out under uncompressed conditions (defined as 10 g initial force) and then with increasing uniaxial compression (10, 15, 20 and 25%), applied by narrowing the gap between the platform and upper platen of the rheometer. The shear storage modulus (G’) was plotted against time (for dynamic time sweep test) or strain (for the strain sweep test), and the shear modulus G was plotted against time (stress relaxation test).
For tension experiments, samples were attached to rheometer platforms with fibrin glue made by mixing equal volumes of 5 mg/ml salmon fibrinogen and 150 U/ml salmon thrombin (Sea Run Holdings, Freeport, ME) immediately before use. 100 μl of the glue was applied to each side of the sample, touching the lower platform and upper platen. 2 g of initial force were applied, the sample was allowed to sit for 5 min to attach to the metal surfaces, and then the force was brought to 10 g. Measurements were taken in the following order: uncompressed (defined as 10 g initial force), 10% tension, and 20% tension. In control experiments, G’ of livers was measured with and without glue and was found to be unchanged, indicating that the glue did not affect the mechanics of the system.
For tension and compression experiments, the following correction was applied to account for the change in cross-sectional area during testing under the assumption that total tissue volume is conserved, where G’ is the storage modulus and λ is axial strain. A similar correction was applied to the loss modulus G”.
For reversibility experiments, livers were subject to strain sweeps from 1% to approximately 45% strain. The rheometer was then quickly reset (less than 10 s) and a strain sweep from approximately 50% to 5% was carried out. The rheometer was again quickly reset and the 1% to 45% sweep repeated, to a total of 3 cycles. This was done for 3 individual livers.
Full text: Click here
Publication 2016
Exercise Tests Fibrinogen Fibrin Tissue Adhesive G Force Hemoglobin, Sickle Liver Mechanics Metals Salmo salar Strains Thrombin Tissues

Most recents protocols related to «Fibrin Tissue Adhesive»

Further, to study the sealing effect of hydrogels, an ex vivo burst pressure experiment [46 ] was conducted. The experimental set up was assembled by referring to a previously published [47 (link)] method with few modifications. A piece of esophageal mucosa of diameter 5 cm was cut out from pig esophagus obtained from Tokyo Shibaura Organ Co., Ltd., then placed tightly over the custom-made sealing device (Figure 2). The device was assembled such that a circular gap of diameter 2 cm exposed the mucosal tissue. A 2 mm diameter incision was made on top of the tissue using a biopsy punch. A total of 1 ml each of 1% w/v CGG-BA at pH 5, 7.4, and 10 were placed in the gap over the mucosa, covering the incision. Fibrin glue was also tested as a control material. The thickness of the hydrogels applied was roughly 4 mm. All the samples were incubated at 37°C for 30 min before measurement. The resistive pressure that the hydrogel can withstand when phosphate-buffered saline (PBS) was ejected at a flow rate of 10 ml min−1. The flow was controlled by a syringe connected to a syringe pump (ELCM2WF 10K-AP, Oriental Motor, Tokyo, Japan) [48 ]. The pressure drop resisted by the hydrogel over the tissue was measured using a pressure gauge (AP-12s, Keyence Corporation, Osaka, Japan). The pressure-drop corresponding to the failure of the gel was noted as the burst pressure.

(a) Schematic of the burst pressure measurement, (b) Image of the experimental setup.

Full text: Click here
Publication 2023
Asian Persons Biopsy Esophageal Mucosa Esophagus Fibrin Tissue Adhesive Hydrogels Medical Devices Mucous Membrane PEGDMA Hydrogel Phosphates Pressure Saline Solution Syringes Tissues
Cationic guar gum (Jaguar® Excel; Mw = 1,000,000 − 1,500,000, degree of substitution = 0.10 − 0.13) [15 ] was kindly provided by Sansho Corporation (Tokyo, Japan). Boric acid (H3BO3), sodium hydroxide (NaOH), potassium chloride (KCl), sodium phosphate dibasic, potassium phosphate monobasic, sodium chloride (NaCl), Dulbecco’s modified Eagle’s medium (DMEM), penicillin-streptomycin-amphotericin B suspension (PSA-B), and fetal bovine serum (FBS) were purchased from Fujifilm Wako Pure Chemical Industries Ltd. (Osaka, Japan). Fibrin glue, Beriplast® P, was obtained from CSL Behring (Pennsylvania, United States).
Full text: Click here
Publication 2023
Amphotericin Amphotericin B Beriplast boric acid Cations Eagle Fetal Bovine Serum Fibrin Tissue Adhesive guar gum Jaguars Penicillins phenethicillin Potassium Chloride potassium phosphate Sodium Chloride Sodium Hydroxide sodium phosphate Streptomycin
Thirty-two 16-week-old male Sprague–Dawley rats, weighing 400–500 g, were used to assess in vivo bone regeneration. Rats were allowed to acclimate to their diet, water, and housing for 1 week prior to surgery. Before the surgical procedure was carried out, rats were anesthetized with 4 MAC of isoflurane (Hana Pharm, Seoul, Korea) in the induction cage and maintained with 1.5 ~ 2 MAC via a face mask at an O2 flow rate of 1–2 L/min. Tramadol (12.5 mg/kg; Hanall Biopharma, Seoul, Korea) and enrofloxacin (Baytril®, 5 mg/kg; Bayer, Leverkusen, Germany) were injected subcutaneously as preoperative analgesic and antibiotic, respectively. The surgical site was clipped, disinfected with chlorhexidine–alcohol solution, and draped with a sterile drape. The skin was incised on the midline of the skull, and the subcutaneous tissue and periosteum were incised and retracted to expose the calvarium. Bilateral calvarial defects, 5 mm in diameter, were generated using a trephine burr with a dental unit and flushed with normal saline to avoid overheating. Each bone defect was filled with 20 mg ceramic beads. Only ceramic beads were implanted in the bead control group, BMP-2 (1 µg/defect) or quercetin (8 wt%)-loaded ceramic beads were implanted in the experimental groups, and the defects were left empty in the negative control group. Fibrin glue (Greenplast®; Green Cross, Seoul, Korea) was applied to the implanted beads to prevent their migration. The periosteum, muscle, and subcutaneous tissue were sutured using 4–0 absorbable suture material (Ethicon, Edinburgh, UK), and the skin was closed using a 4–0 nylon monofilament suture (AILEE Co., Busan, Korea). All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of the Seoul National University (SNU-200612-4).
Full text: Click here
Publication 2023
Analgesics Animals Antibiotics Baytril Bone Morphogenetic Protein 2 Bone Regeneration Bones Calvaria Chlorhexidine Cranium Dental Health Services Diet Enrofloxacin Ethanol Fibrin Tissue Adhesive Institutional Animal Care and Use Committees Isoflurane Macrophage-1 Antigen Males Muscle Tissue Normal Saline Nylons Operative Surgical Procedures Periosteum Quercetin Rats, Sprague-Dawley Rattus norvegicus RCE1 protein, human Skin Sterility, Reproductive Subcutaneous Fat Sutures Tramadol Trephining
Fibrin scaffold containing NKs and WJ-MSCs was prepared with fibrinogen and thrombin contained within the commercial fibrin sealant TISSEEL (Baxter, Vienna, Austria). Fibrinogen and thrombin were diluted before use to working concentration 20 mg/mL and 10 IU/mL, respectively, with DPBS (BioWest, Nuaillé, France). Per one 96-well plate well, cells (2 × 105 NKs + 2 × 104 WJ-MSCs/WJ-MSCs-TRAI) were resuspended in 15 μL of thrombin and after placing into the well, the suspension was covered with 15 μL of fibrinogen. After 5 min in 37 °C, originated fibrin scaffold containing cells was covered with 150 μL of full RPMI 1640 medium (BioWest, Nuaillé, France).
Full text: Click here
Publication 2023
Cells Fibrin Fibrinogen Fibrin Tissue Adhesive Thrombin Tisseel
Patients were laid in the supine position with the head tilted back approximately 20°. A right nostril approach was used. Under the operating microscope, the nasal septum mucosa was cut transversely 2.5 cm from the tip of the nose and separated to the anterior wall of the sphenoid sinus. At the junction of the vertical plate of the ethmoid bone and the anterior wall of the sphenoid sinus, the bone of the nasal septum was broken and pushed away to the opposite side. A nasal dilator was used to stretch the nasal septum mucosa on both sides and expand the visual field of the anterior wall of the sphenoid sinus. After having confirmed the ostium of the sphenoid sinus, the anterior wall of the sphenoid sinus was ground off, the sphenoid sinus was entered, the septum of the sphenoid sinus was ground off, the sellar base was identified and exposed, and a bone window was opened with a diameter of 1.5–2 cm in the anterior wall of the sellar base. An X-cut of the dura mater at the bottom of the saddle was made to observe the tumour tissue. The tumour was carefully removed using a suction device, a scraping ring, and tumour forceps in a back, top, and front order. The surrounding normal pituitary tissue was fully identified and preserved. A gelatin sponge was used to stem the bleeding. Finally, freeze-dried fibrin glue (Shanghai Laishi 2 mL/branch) was used to fix the tissue. If cerebrospinal fluid leakage occurred intraoperatively, the sellar base was closed with an artificial dura. Osseous reconstruction of the sellar floor and foreign body packing in the sphenoid sinus cavity were not performed. Both nasal cavities were filled with surgical polyvinyl alcohol sponge and removed on post-operative day three.
Full text: Click here
Publication 2023
Bones Dental Caries Dura Mater Ethmoid Bone Fibrin Tissue Adhesive Forceps Forehead Freezing Gelatins Head Leak, Cerebrospinal Fluid Medical Devices Microscopy Nasal Bone Nasal Cavity Nasal Mucosa Neoplasms Nose Patients Polyvinyl Alcohol Porifera Reconstructive Surgical Procedures Sphenoid Sinus Stem, Plant Suction Drainage Surgical Sponges Tissues

Top products related to «Fibrin Tissue Adhesive»

Sourced in United States, United Kingdom
Tisseel is a surgical sealant and fibrin tissue adhesive product. It is designed to provide hemostasis and tissue sealing during surgical procedures. Tisseel is composed of human-derived fibrinogen and thrombin components that, when mixed, form a fibrin clot to assist in wound sealing.
Sourced in United States
TISSEEL fibrin sealant is a sterile, biocompatible, and biodegradable medical device. It is composed of human-derived fibrinogen and thrombin, which when mixed, form a fibrin clot to facilitate hemostasis and wound healing.
Sourced in United States
Fibrin glue is a surgical adhesive product used in medical procedures. It is composed of fibrinogen and thrombin, which when combined, form a fibrin clot that can be used to seal wounds and facilitate tissue healing. The core function of fibrin glue is to provide a natural, biocompatible sealant for various surgical applications.
Sourced in United Kingdom, Australia
The Tisseel Kit is a surgical sealant product that contains a sealing protein and a thrombin solution. It is designed to be used as an adjunct to standard surgical techniques for the sealing of bleeding and fluid leaks.
Sourced in Germany, United States
Tissucol is a surgical sealant product developed by Baxter. It is a fibrin-based biological adhesive used to assist in hemostasis and tissue sealing during surgical procedures.
Sourced in United States, France
Evicel is a surgical sealant product developed by Johnson & Johnson. It is a two-component fibrin sealant that helps control bleeding during surgical procedures.
Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe, Switzerland, Sweden, Ireland, Macao, India, Australia, France, Spain
Thrombin is a serine protease enzyme that plays a crucial role in the blood coagulation process. It is responsible for the conversion of fibrinogen to fibrin, which is the main structural component of blood clots. Thrombin also activates other factors involved in the clotting cascade, promoting the formation and stabilization of blood clots.
Sourced in Switzerland
Chondro-Gide is a collagen membrane developed by Geistlich Pharma for the repair and regeneration of cartilage.
Sourced in United States, United Kingdom
ARTISS is a sterile, fibrin sealant product designed for use as an adjunct to hemostasis in surgery. It is composed of human plasma-derived fibrinogen and thrombin.
Sourced in United States, Germany, United Kingdom, Canada, Macao, Japan, France, Switzerland, Hungary, Italy, China
Fibrinogen is a plasma protein that plays a crucial role in the blood clotting process. It is a component of the coagulation cascade and is essential for the formation of fibrin clots.

More about "Fibrin Tissue Adhesive"

Fibrin Tissue Adhesive, also known as Tisseel, TISSEEL fibrin sealant, Fibrin glue, Tisseel Kit, Tissucol, Evicel, and ARTISS, is a versatile biological adhesive derived from human fibrinogen and thrombin.
It is widely used in various medical and surgical applications, including wound closure, hemostasis, and tissue engineering.
Fibrin Tissue Adhesive functions by mimicking the final stage of the coagulation cascade, forming a fibrin clot that adheres to tissue surfaces.
This adhesive is particularly valuable in the field of regenerative medicine and wound management, where its unique properties make it a powerful tool for clinicians and researchers.
It can be used to promote hemostasis, seal tissue, and support tissue repair and healing.
Chondro-Gide, a collagen-based matrix, is often used in conjunction with Fibrin Tissue Adhesive for cartilage repair and regeneration.
Fibrin Tissue Adhesive is a versatile and reliable solution for a wide range of medical and surgical applications.
Its ability to mimic the natural coagulation process and its strong adhesive properties make it a valuable asset in various fields, including orthopedics, neurosurgery, cardiovascular surgery, and more.
By leveraging the latest advancements in the field, researchers and clinicians can optimize their Fibrin Tissue Adhesive research and maximize its potential for improved patient outcomes.